Ingevity
NGVT
253 hedge funds and large institutions have $2.22B invested in Ingevity in 2017 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 80 increasing their positions, 86 reducing their positions, and 29 closing their positions.
481% more call options, than puts
Call options by funds: $1.37M | Put options by funds: $235K
14% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 29
1% more funds holding
Funds holding: 250 → 253 (+3)
7% less repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 86
2.13% less ownership
Funds ownership: 93.91% → 91.78% (-2.1%)
8% less capital invested
Capital invested by funds: $2.41B → $2.22B (-$189M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
Top Sellers
NGVT Hedge Fund Activity: Q2 2017 in Review
253 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Ingevity (NGVT) for Q2 2017, worth a combined $2.22B — down 7.8% from $2.41B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new NGVT positions and 29 closed out — a net gain of 4 holders — while 80 added to existing stakes and 86 trimmed.
The largest buyer was Loomis, Sayles & Company, adding an estimated $21.1M. The largest seller was Maple Rock Capital Partners, cutting an estimated $26.2M.
- 253 institutional investors held Ingevity (NGVT) as of Q2 2017, up from 250 in Q1 2017.
- Funds reported $2.22B of Ingevity stock for Q2 2017, down 7.8% quarter-over-quarter.
- 33 funds opened new Ingevity positions in Q2 2017 and 29 closed out, a net change of +4 holders.
- The largest Ingevity buyer in Q2 2017 was Loomis, Sayles & Company, an estimated $21.1M added.
- The largest Ingevity seller in Q2 2017 was Maple Rock Capital Partners, an estimated $26.2M sold.
Based on aggregated 13F filings for Q2 2017.